Delivery Order SPE2DR25D1053-SPE2DR26FV031
- Not listed
- The Defense Logistics Agency awarded a $50,724.85 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, which is not set-aside designated, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration, with a ceiling value of $13,819.64. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $30,851.70 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,754.49 to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $29,947.68 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, was competitively awarded with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,279.40 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 19, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $43,255 delivery order to AmerisourceBergen Drug Corp for 60 units of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. The award, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $6,143.50 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory treatment, with delivery to the company's Conshohocken, Pennsylvania location. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract carries no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order valued at $39,958.00 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitive, non-set-aside delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a $24,798.14 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (60-count units), a combination inhaler medication used to treat chronic obstructive pulmonary disease. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV031Delivery Order
The Defense Logistics Agency awarded a $39,043.24 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. The award represents a competitive, firm fixed-price delivery order with an ultimate completion date of December 30, 2025, and carries no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal military and veteran healthcare systems, AmerisourceBergen leverages this prime contract vehicle to supply a comprehensive range of medications and medical commodities to support the Defense Health Agency and other government healthcare operations worldwide. The current award exemplifies the contractor's role in fulfilling routine pharmaceutical procurement needs within the military supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 12/28/25 |